Temporally controlled onset of dilated cardiomyopathy through disruption of the srf gene in adult heart

Circulation

Volumn 112, Issue 19, 2005, Pages 2930-2939

  Parlakian, Ara ^a   Charvet, Claude ^b   Escoubet, Brigitte ^a   Mericskay, Mathias ^f   Molkentin, Jeffery D ^c   Gary Bobo, Guillaume ^f   De Windt, Leon J ^d   Ludosky, Marie Aline ^e   Paulin, Denise ^a   Daegelen, Dominique ^b   Tuil, David ^b   Li, Zhenlin ^f,g  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITY OF CINCINNATI   (United States)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e INSTITUT JACQUES MONOD   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g CNRS   (France)

Author keywords

Cardiomyopathy; Contractility; Echocardiography; Genes; Heart failure; Molecular biology; Myocardium

Indexed keywords

ALPHA ACTIN; CRE RECOMBINASE; CREATINE KINASE; MESSENGER RNA; SERUM RESPONSE FACTOR; TAMOXIFEN; TRANSCRIPTION FACTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOARCHITECTURE; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; GENE DISRUPTION; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FAILURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SRF GENE;

ANIMALS; CARDIOMYOPATHY, DILATED; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; FEMALE; HEART; HOMOZYGOTE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERUM RESPONSE FACTOR;

EID: 27744569175     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.533778     Document Type: Article

References (39)

1. Olson EN, Schneider MD. Sizing up the heart: development redux in disease. Genes Dev. 2003;17:1937-1956.
2. Molkentin JD. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res. 2004;63:467-475.
3. Ritter O, Neyses L. The molecular basis of myocardial hypertrophy and heart failure. Trends Mol Med. 2003;9:313-321.
4. Nabel EG. Cardiovascular disease. N Engl J Med. 2003;349:60-72.
5. Sussman MA, McCulloch A, Borg TK. Dance band on the Titanic: biomechanical signaling in cardiac hypertrophy. Circ Res. 2002;91:888-898.
6. Roberts R, Schwartz K. Myocardial diseases. Circulation. 2000;102: IV34-1V39.
7. McNally E, Allikian M, Wheeler MT, Mislow JM, Heydemann A. Cytoskeletal defects in cardiomyopathy. J Mol Cell Cardiol. 2003;35:231-241.
8. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell. 2001;104:557-567.
9. Dalloz F, Osinska H, Robbins J. Manipulating the contractile apparatus: genetically defined animal models of cardiovascular disease. J Mol Cell Cardiol. 2001;33:9-25.
10. Schwartz K, Mercadier JJ. Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair. J Clin Invest. 2003;112:652-654.
11. Treisman R, Ammerer G. The SRF and MCM1 transcription factors. Curr Opin Genet Dev. 1992;2:221-226.
12. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol. 2003;35:577-593.
13. Sepulveda JL, Vlahopoulos S, Iyer D, Belaguli N, Schwartz RJ. Combinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity. J Biol Chem. 2002;277:25775-25782.
14. Morin S, Paradis P, Aries A, Nemer M. Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol Cell Biol. 2001;21:1036-1044.
15. Davis FJ, Gupta M, Pogwizd SM, Bacha E, Jeevanandam V, Gupta M. Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts. Am J Physiol. 2002;282: H1521-H1533.
16. Chang J, Wei L, Otani T, Youker KA, Entman ML, Schwartz RJ. Inhibitory cardiac transcription factor, SRF-N, is generated by caspase 3 cleavage in human heart failure and attenuated by ventricular unloading. Circulation. 2003;108:407-413.
17. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 1998;17:6289-6299.
18. Parlakian A, Tuil D, Hamard G, Tavernier G, Hentzen D, Concordet JP, Paulin D, Li Z, Daegelen D. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol. 2004;24:5281-5289.
19. Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, Balza RO Jr, Xiao Q, Weiler H, Ginty DD, Misra RP. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A. 2004;101:17132-17137.
20. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89:20-25.
21. Gamier A, Bendall JK, Escoubet B, Rochais F, Hoerter J, Nehme J, Ambroisine ML, De Angelis N, Morineau G, d'Estinenne P, Fischmeister R, Heymes C, Pinet F, Delacyre C. Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice. Circulation. 2004;110:1819-1825.
22. 2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias. Circulation. 2004;109:1898-1903.
23. Royer A, Van Veen TAB, Le Bouter S, Marionneau C, Griol-Charhbili V, Leoni A-L, Steenman M, Van Rijen H, Demolombe S, Goddard CA, Richard C, Escoubet B, Jarry-Guichard T, Colledge WH, Gris D, de Bakker JMT, Grace AA, Escande D, Charpentier F. A mouse model of SCNA-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation. 2005;111:1738-1746.
24. Prunier F, Gaertner R, Louedec L, Michel JB, Mercadier JJ, Escoubet B. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol. 2002;283:H346-H352.
25. Agbulut O, Li Z, Perie S, Ludosky MA, Paulin D, Cartaud J, Butler-Browne G. Lack of desmin results in abortive muscle regeneration and modifications in synaptic structure. Cell Motil Cytoskeleton. 2001;49:51-66.
26. Soulez M, Gauthier-Rouvière C, Chafey P, Hentzen D. Vandromme M, Lautredou N, Lamb N, Kahn Tuil D. Growth and differentiation of C2 myogenic cell are dependent on serum response factor. Mol Cell Biol. 1996;16:6065-6074.
27. Schratt G, Philippar U, Berger J, Schwarz H, Heidenreich O, Nordheim A. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J Cell Biol. 2002;156:737-750.
28. Gupta MP, Amin CS, Gupta M, Hay N, Zak R. Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein. Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol. 1997;17:3924-3936.
29. Baker DL, Dave V, Reed T, Misra S, Periasamy M, A novel E box/AT-rich element is required for muscle-specific expression of the sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene. Nucleic Acids Res. 1998;26:1092-1098.
30. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998;280:750-752.
31. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature. 2002;420:629-635.
32. Perriard JC, Hirschy A, Ehler E. Dilated cardiomyopathy: a disease of the intercalated disc? Trends Cardiovasc Med. 2003;13:30-38.
33. Ehler E, Horowits R, Zuppinger C, Price RL, Perriard E, Leu M, Caroni P, Sussman M, Eppenberger HM, Perriard JC. Alterations at the intercalated disk associated with the absence of muscle LIM protein. J Cell Biol. 2001;153:763-772.
34. Ferreira-Cornwell MC, Luo Y, Narula N, Lenox JM, Lieberman M, Radice GL. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci. 2002;115:1623-1634.
35. Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV, Molkentin JD, Radice GL. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res. 2005;96:346-354.
36. Spindler M, Meyer K, Stromer H, Leupold A, Boehm E, Wagner H, Neubauer S. Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis. Am J Physiol. 2004;287:H1039-H1045.
37. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R. Subcellular creatine kinase alterations: implications in heart failure. Circ Res. 1999;85:68-76.
38. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J, Misra RP, Wei JY. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol. 2001;280:H1782-H1792.
39. Zhang X, Chai J, Azhar G, Sheridan P, Borras AM, Furr MC, Khrapko K, Lawitts J, Misra RP, Wei JY. Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem. 2001;276:40033-40040.